Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:24 PM ET 10-Q
Financial Results Worthington Steel, Inc. WS

Worthington Steel Q1 2027 Results

Worthington Steel, Inc. filed this 10-Q for the quarter ended August 31, 2026, following its December 2023 separation from Worthington Enterprises. The report highlights the significant acquisition of Klöckner & Co SE and the pending sale of the company's Becker operations as key strategic developments. Forward-looking statements emphasize integration synergies, potential financial obligations under a Domination and Profit and Loss Transfer Agreement, and the impact of volatile steel pricing on margins.

4:17 PM ET 8-K
Financial Results Azz Inc AZZ

Azz Financial Results

AZZ Inc. reported record second quarter fiscal year 2027 results with sales of $486.9 million, up 16.7% year-over-year, and adjusted diluted EPS of $2.00. The company raised its full-year 2027 guidance based on strong sales momentum in its Metal Coatings and Precoat Metals segments and robust operating cash flow of $102.8 million for the quarter.

Term
Q2 2027

“Our record second-quarter sales of $486.9 million, up 16.7%, reflects not only strong execution but also the strength of our long-term strategy and the durability of our business model.”

Tom Ferguson, President, and Chief Executive Officer of AZZ

“I am pleased with our record-setting performance during the first half of the year and we are on track to set new sales and profitability records for fiscal year 2027. We are increasing our annual financial guidance to reflect our quarterly performance, sustained sales momentum across both segments and increased confidence in our outlook for the remainder of fiscal year 2027.”

Tom Ferguson, President, and Chief Executive Officer of AZZ
4:16 PM ET 10-Q
Financial Results Azz Inc AZZ

Azz Q2 2026 Results: Net Income $58.5M, Down 34.6% YoY

AZZ INC reported net income of $58.5 million for the quarter ended August 31, 2026, a decrease from $89.3 million in the prior year period, primarily due to a significant reduction in equity earnings from its AVAIL joint venture. Despite lower net income, sales grew 16.7% to $486.9 million, and the company increased its quarterly cash dividend to $0.24 per share.

Key figure
Net income $58.5M · -34.6% YoY
4:16 PM ET 10-K
Financial Results Advanced Biomed Inc. ADVB

Advanced Biomed FY 2026 Results: Turns Profitable, Net Income $6.68M

Advanced Biomed Inc. reported a net income of $6.68 million for fiscal 2026, a significant turnaround from a $3.26 million loss in 2025, primarily driven by a $14.02 million gain on the disposal of its biotechnology subsidiaries. The company has pivoted to AI and financial algorithmic software, generating its first $127,637 in revenue from these operations while managing a $6.26 million loss from continuing operations due to high stock-based compensation and credit loss provisions.

Key figure
Net income $6.68M
4:06 PM ET 8-K
Financial Results Solitron Devices Inc SODI

Solitron Devices Financial Results

Solitron Devices reported fiscal 2027 second quarter net sales of $5.66 million, a 42% increase year-over-year, and net income of $1.30 million compared to a net loss in the prior year period. The company's backlog reached a record $24.11 million, driven by demand for components on missile programs such as AMRAAM and Standard Missiles.

Term
Q2 2027
4:06 PM ET 10-Q
Financial Results Solitron Devices Inc SODI

Solitron Devices Q2 2026 Results: Turns Profitable, Net Income $1.3M

Solitron Devices reported a significant increase in net sales to $11.1 million for the six months ended August 31, 2026, compared to $6.7 million in the prior year period. The company achieved a net income of $2.3 million for the first half of fiscal 2027, a substantial turnaround from the $0.6 million net loss reported in the same period of fiscal 2026.

Key figure
Net income $1.3M
4:05 PM ET 10-K
Financial Results Zeo ScientifiX, Inc. ZEOX

Zeo ScientifiX FY 2025 Results: Net Loss of $5.52M, Loss Widens

Zeo ScientifiX, Inc. reported a working capital deficit of $1,915,000 as of October 31, 2025, which improved to a positive $65,000 by June 30, 2026. The company remains dependent on external investment capital to fund operations and faces significant risks regarding supply chain stability and its ability to continue as a going concern.

Key figure
Net loss $5.52M
4:02 PM ET 10-K
Financial Results Okmin Resources, Inc. OKMN

Okmin Resources FY 2026 Results: Net Loss of $367K, Loss Narrows

OKMIN RESOURCES, INC. is an early-stage exploration company with no proven oil and gas reserves and limited capital, necessitating future equity raises to fund operations. The company faces significant operational risks as a non-operator and is highly sensitive to volatile commodity prices, which recently spiked over $100 per barrel due to Middle East conflicts.

Key figure
Net loss $367K
4:01 PM ET 10-K
Financial Results Escalon Medical Corp ESMC

Escalon Medical FY 2026 Results: Net Income $4.01M, Up 3702.5% YoY

Escalon Medical Corp. reported a significant increase in net income to $4,012,626 for the fiscal year ended June 30, 2026, primarily driven by a $2,813,525 gain from the sale of AXIS software and a $1,139,449 income tax benefit. Total revenues grew slightly to $12.7 million, while the company strengthened its cash position to over $3 million by year-end.

Key figure
Net income $4.01M · +3702.5% YoY
3:05 PM ET 10-Q
Financial Results Bab, Inc. BABB

Bab Q3 2026 Results: Net Income $227K, Up 35.6% YoY

BAB, Inc. reported a net income of $533,428 for the nine months ended August 31, 2026, an increase from $438,188 in the prior year period. Total revenues grew to $2.44 million, driven by higher royalty and marketing fund revenues, while the company maintained a strong cash position of $2.75 million.

Key figure
Net income $227K · +35.6% YoY
2:47 PM ET 10-K
Financial Results MedWellAI, Inc. MWAI

MedWellAI FY 2026 Results: Net Loss of $1.59M, Loss Narrows

MedWellAI, Inc. reported a net loss of $1,589,465 for the fiscal year ended June 30, 2026, an improvement from a $3,607,145 loss in 2025 as it transitioned from digital asset mining to the health and wellness industry. The company faces significant liquidity challenges with a stockholders' deficit of $7,979,411 and an accumulated deficit of over $90 million, leading to a substantial doubt about its ability to continue as a going concern.

Key figure
Net loss $1.59M
2:32 PM ET 10-Q
Financial Results Anvi Global Holdings, Inc. ANVI

Anvi Global Holdings Q2 2026 Results: Net Loss of $57.8K, Loss Widens

Anvi Global Holdings, Inc. reported a net loss of $110,707 for the six months ended August 31, 2026, compared to a loss of $105,270 in the prior year period. The company remains in a significant stockholders' deficit of $2,471,606 and is currently funded through advances from an officer to cover its general and administrative expenses.

Key figure
Net loss $57.8K
12:51 PM ET 10-K
Financial Results Yan Chuang Group Inc.

Yan Chuang Group FY 2026 Results: Net Loss of $75.4K

Yan Chuang Group Inc. is a development-stage fintech company that has generated no revenue to date and reported a net loss of $75,448 for the fiscal year ended June 30, 2026. The company's auditors have issued a going concern warning due to its accumulated deficit of $104,215 and dependence on successful fundraising through its initial public offering.

Key figure
Net loss $75.4K
12:48 PM ET 10-Q
Financial Results Cybriatech Inc

Cybriatech Q3 2026 Results: Net Loss of $5.34K, Loss Narrows

Cybriatech Inc. reported a small net income of $598 for the nine months ended August 31, 2026, compared to a net loss of $24,009 in the prior year period. Despite the marginal profit, the company maintains an accumulated deficit of $30,211 and management expressed substantial doubt about its ability to continue as a going concern without additional investment capital.

Key figure
Net loss $5.34K
12:26 PM ET 10-Q
Financial Results National Rural Utilities Cooperative Finance Corp NRUC

National Rural Utilities Cooperative Finance Q1 2026 Results: Net Income $135M, Up 2730.8% YoY

National Rural Utilities Cooperative Finance Corp (CFC) is a tax-exempt cooperative providing financing to rural electric and telecommunication systems. For the period ending August 31, 2026, the company continues to fund operations through debt issuances and member investments, focusing on cost-based financial products rather than profit maximization.

Key figure
Net income $135M · +2730.8% YoY
12:17 PM ET 10-Q
Financial Results Arts Way Manufacturing Co Inc ARTW

Arts Way Manufacturing Co Q3 2026 Results: Net Loss of $140K

Art’s-Way Manufacturing reported net income of $230,200 for the nine months ended August 31, 2026, a significant decrease from $1,680,423 in the prior year period despite a 12.3% increase in total sales. The decline in profitability was driven by higher cost of goods sold, increased operating expenses, and the absence of a large one-time 'Other' income gain recorded in 2025.

Key figure
Net loss $140K
10:10 AM ET 8-K
Financial Results Citigroup Inc C

Citigroup Financial Results

Citigroup reported Q3 2026 net income of $5.2 billion ($2.85 per diluted share) on revenues of $23.8 billion, an 8% increase year-over-year. The results were driven by growth in Services, Wealth, Markets, and Banking, alongside lower operating expenses. The company returned $4.1 billion to shareholders through common share repurchases and dividends during the quarter.

Term
Q3 2026

“Our performance in the quarter, which included the best third-quarter revenue in a decade, positive operating leverage and meaningful improvement in our returns, reflects the continued disciplined and consistent execution of our strategy.”

Jane Fraser, Citi Chair and CEO

“We returned over $4 billion to common shareholders while continuing to invest in growth and prepare for an AI-driven future. We expect to exceed this year's return target, even as we pull forward investments toward our 11-13% near-term goal —the next waypoints on our path to sustainable returns of 14-15%”

Jane Fraser, Citi Chair and CEO
9:46 AM ET 10-Q
Financial Results Made in USA Inc. USDW

Made in USA Q2 2026 Results: Net Loss of $1.74K

MADE IN USA INC. reported a net loss of $4,724 for the six months ended August 31, 2026, as the company transitions its business model toward blockchain and AI-based supply chain validation. A significant asset acquisition occurred during the period, with the issuance of 5,000,000 shares for $25,000,000 in intangible technology assets.

Key figure
Net loss $1.74K
9:40 AM ET 8-K
Financial Results Jpmorgan Chase & Co JPM

Jpmorgan Chase & Financial Results

JPMorgan Chase reported Q3 2026 net income of $15.3 billion and earnings per share of $5.57 on managed revenue of $50.9 billion. The results were driven by a 13% year-over-year increase in net interest income and strong performance in Equity Markets, partially offset by higher compensation and technology expenses.

Term
Q3 2026
9:01 AM ET 10-Q
Financial Results Wenyuan Group Corp. WYGC

Wenyuan Group Q2 2026 Results: Net Loss of $52.4K, Loss Narrows

Wenyuan Group Corp. reported zero revenue for the three and six months ended June 30, 2026, resulting in a net loss of $116,090 for the first half of the year. The company's stockholders' deficit increased to $129,698 as of June 30, 2026, compared to $12,068 at the end of 2025, primarily due to ongoing operating expenses and a lack of sales.

Key figure
Net loss $52.4K
9:00 AM ET 10-K
Financial Results Birdie Win Corp BRWC

Birdie Win FY 2026 Results: Net Loss of $27.5K, Loss Widens

Birdie Win Corp reported a net loss of $27,474 for the fiscal year ended July 31, 2026, on revenues of $20,000, which decreased from $30,000 in 2025. The company faces substantial doubt about its ability to continue as a going concern due to a working capital deficit of $13,104 and an accumulated deficit of $102,669.

Key figure
Net loss $27.5K
8:13 AM ET 8-K
Financial Results Johnson & Johnson JNJ

Johnson & Johnson Financial Results

Johnson & Johnson reported Q3 2026 sales growth of 5.9% to $25.4 billion, driven by strong performance in its Innovative Medicine and MedTech segments. The company raised its full-year 2026 guidance for both sales and adjusted EPS, despite a GAAP earnings impact from a one-time special charge related to talc litigation and recent M&A activity.

Term
Q3 2026

“Johnson & Johnson’s strong third-quarter performance and increased sequential growth reflect the accelerating momentum of our focused portfolio.”

Joaquin Duato, Chairman and Chief Executive Officer

“This progress, together with strategic investments in high-growth areas, gives us clearer line of sight to double-digit growth by the end of the decade.”

Joaquin Duato, Chairman and Chief Executive Officer
7:33 AM ET 8-K
Financial Results Goldman Sachs Group Inc GS

Goldman Sachs Group Financial Results

The Goldman Sachs Group, Inc. reported its financial results for the third quarter ended September 30, 2026. The company also scheduled a conference call to discuss the results and its future outlook, providing a formal presentation deck as part of the disclosure.

Term
Q3 2026
7:31 AM ET 8-K
Financial Results Albertsons Companies, Inc. ACI

Albertsons Companies Financial Results

Albertsons Companies reported second quarter fiscal 2026 net sales of $18.9 billion and net income of $52 million, or $0.11 per share. The company saw an 11% increase in digital sales but an 0.8% decrease in identical sales, leading management to launch a comprehensive business review to simplify the organization and reduce costs.

Term
Q2 2026

“Although our second quarter performance was in-line with the expectations in our revised outlook, our results do not reflect the potential of the Company. We are launching a comprehensive business review to speed up improvements in Albertsons' performance and tackle even harder a cost structure we can no longer afford. Our work will find opportunities to simplify the organization, improve decision-making, reinvest savings in customer value, and boost long-term shareholder returns.”

Susan Morris, Chief Executive Officer
6:34 AM ET 10-Q
Financial Results Norris Industries, Inc. NRIS

Norris Industries Q2 2026 Results: Net Loss of $161K, Loss Widens

Norris Industries, Inc. reported a net loss of $403,621 for the six months ended August 31, 2026, compared to a loss of $319,297 in the prior year period. The company faces liquidity challenges with a stockholders' deficit of $5.25 million, though it maintains a $600,000 credit line with a related party to fund ongoing oil and gas operations in Texas.

Key figure
Net loss $161K
6:29 AM ET 8-K
Financial Results Wells Fargo & Company WFC

Wells Fargo & Financial Results

Wells Fargo reported third quarter 2026 net income of $6.0 billion, or $1.87 per diluted share, on total revenue of $21.87 billion. The results were driven by broad-based growth across operating segments, including a 12% revenue increase in Wealth and Investment Management and an 11% increase in both average loans and deposits. The company also repurchased $2.5 billion of common stock during the quarter.

Term
Q3 2026

“Our third quarter results reflect broad-based growth, higher earnings, and stronger returns. Diluted earnings per share increased to $1.87 in the third quarter, up 13% from a year ago. Our ROTCE increased from 14.7% during the first nine months of 2025 to 16.2% during the same period this year and 16.3% in the third quarter. Both average loans and average deposits increased 11% from a year ago.”

Charlie Scharf, Chairman and Chief Executive Officer

“While economic uncertainty exists and consumer sentiment remains mixed, our data shows that our consumer and business customers are doing well. Consumers are spending more, loan delinquencies are low, and deposit and investment balances have grown. Businesses continue to have strong balance sheets and losses remain low. While higher interest rates, higher oil prices and persistent inflation create risks to the economy, strong positive forces such as the investment in AI infrastructure, high employment levels and consistent wage growth continue to outweigh the risks”

Charlie Scharf, Chairman and Chief Executive Officer
6:22 AM ET 10-Q
Financial Results Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics Q3 2026 Results: Turns Profitable, Net Income $550M

Nurix Therapeutics reported a significant swing to profitability for the quarter ended August 31, 2026, with net income of $549.8 million compared to a net loss of $86.4 million in the prior year, primarily driven by $653.2 million in license revenue. The company's cash position strengthened significantly to $720.2 million, up from $247.0 million at the end of fiscal 2025.

Key figure
Net income $550M
6:20 AM ET 8-K
Financial Results Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics Financial Results

Nurix Therapeutics reported financial results for its fiscal third quarter ended August 31, 2026, highlighting a cash position of $1.1 billion following a $700 million upfront payment from its Roche collaboration. The company achieved several clinical milestones, including dosing the first patient in its Phase 3 DAYBreak CLL-306 trial and advancing its STAT6 degrader into Phase 1 with Sanofi.

Term
Q3 2026

“The third quarter marked an important transition for Nurix as we moved bexobrutideg into Phase 3 development in CLL and began executing a broader clinical strategy designed to realize its potential across lines of therapy in both oncology and auto-immune disease.”

Arthur T. Sands, M.D., Ph.D., president and chief executive officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.